HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-15Clinical Trial Update: A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication [Phase 1]
Phase 1 study evaluating drug interactions between a hormonal emergency contraception and an HIV medication; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-15Clinical Trial Update: Preliminary Study of Safety and Efficacy of Policosanol [Phase 2]
Phase 2 trial evaluating the safety and efficacy of policosanol in dyslipidemia and HIV infection has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-07-15Clinical Trial Update: Nutritional Status Among naïve HIV Infected Patients and HIV Infected Patients Receiving Highly Active Antiretroviral Therapy
A completed clinical trial evaluating the nutritional status of HIV-infected individuals who are ART-naïve and those receiving highly active…
-
CLINICAL_TRIALS trial_result · 2013-07-15Clinical Trial Update: Trichomonas Vaginalis Recurrence Among HIV+ Women [Phase 4]
The Phase 4 clinical trial evaluating recurrence of Trichomoniasis in HIV-positive women has completed, with results posted.
-
CLINICAL_TRIALS withdrawal · 2013-07-15Clinical Trial Update: SCOPE: Strategies to Combine PrEP With Prevention Efforts [NA]
The SCOPE trial assessing strategies to combine pre-exposure prophylaxis with HIV prevention efforts has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy
The completed trial evaluated darunavir/ritonavir monotherapy in HIV-infected patients, reporting on darunavir levels, virological efficacy,…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus [Phase 2]
Phase 2 trial evaluating cenicriviroc in combination with Truvada or Sustiva plus Truvada for antiretroviral-naïve adults with CCR5-tropic H…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: A Proof of Concept Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics of the CCR5 Antagonist TBR 652 in HIV 1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients [Phase 1, Phase 2]
A Phase 1/2 proof-of-concept study assessed antiviral activity, safety, and pharmacokinetics of the CCR5 antagonist TBR-652 in HIV-1 infecte…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Information About HIV Transmission and Circumcision on Subsequent Sexual Behavior, and the Demand for Circumcision [NA]
Completed clinical trial assessing whether information about HIV transmission and circumcision influences subsequent sexual behavior and the…
-
CLINICAL_TRIALS trial_result · 2013-07-09Clinical Trial Update: HIV Testing & Womens Attitudes on HIV Vaccine Trials [Phase 3]
Phase 3 HIV vaccine trial update analyzing HIV testing and women's attitudes toward participating in HIV vaccine trials; results were posted…
-
CLINICAL_TRIALS trial_result · 2013-07-09Clinical Trial Update: Potential for Drug-drug Interactions Between Boceprevir and Etravirine in HIV/Hepatitis C Virus Negative Volunteers [NA]
Completed trial evaluating potential drug-drug interactions between boceprevir and etravirine in HIV/Hepatitis C-negative volunteers.
-
CLINICAL_TRIALS trial_result · 2013-07-08Clinical Trial Update: A Phase 2 Study to Evaluate Pharmacokinetics, Safety and Efficacy of TMC114/Ritonavir (Rtv) in Human Immunodeficiency Virus (HIV)-1 Infected Children and Adolescents [Phase 2]
Phase 2 study evaluating pharmacokinetics, safety and efficacy of darunavir/ritonavir (TMC114/ritonavir) in HIV-1 infected children and adol…
-
FDA approval · 2013-07-08FDA Approved: TRUVADA — Supplemental Application (Gilead Sciences, Inc)
The FDA approved a supplemental application for TRUVADA from Gilead Sciences, Inc.
-
FDA approval · 2013-07-08FDA Approved: ETRAVIRINE — Supplemental Application (Patriot Pharmaceuticals)
The FDA approved a supplemental application for ETRAVIRINE submitted by Patriot Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2013-07-08Clinical Trial Update: Enhancing Oral Health Care Use by HIV Positive Individuals [NA]
A completed clinical trial evaluating strategies to increase use of oral health care among HIV-positive individuals.
-
FDA approval · 2013-06-28FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Isentress (raltegravir) from Merck Sharp & Dohme LLC, signaling an update to its labeling/in…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection [Phase 4]
Phase 4 trial results assess the efficacy and safety of a fixed-dose regimen of tenofovir disoproxil fumarate + lamivudine + efavirenz in ad…
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth [Phase 4]
Phase 4 study comparing three Hepatitis B vaccination regimens in HIV-infected youth; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients [Phase 2]
A Phase 2 study comparing a treatment simplification with darunavir/ritonavir (800/100 mg) to a triple-drug regimen containing DRV/r in HIV-…
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: Pregabalin Trial In HIV Neuropathic Pain [Phase 3]
Phase 3 clinical trial of pregabalin for HIV-associated neuropathic pain was terminated; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications. [Phase 3]
A Phase 3 trial of the investigational protease inhibitor TMC114 (darunavir) with ritonavir in HIV-1 infected patients who have never receiv…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Assisting HIV-infected Mothers in Disclosing Their Serostatus to Their Children [Phase 1]
Phase 1 trial evaluating psychosocial strategies to help HIV-infected mothers disclose their serostatus to their children has completed. The…
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz. [Phase 3]
A Phase 3 trial comparing a tenofovir-based regimen (tenofovir disoproxil fumarate with lamivudine and efavirenz) to a stavudine-based regim…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: A Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected Children [Phase 2]
This Phase 2 safety study evaluated the antiviral activity of darunavir in combination with ritonavir in HIV-1 infected children; study resu…
-
FDA approval · 2013-06-21FDA Approved: EDURANT — Supplemental Application (Janssen Products, LP)
FDA approved a supplemental application for Edurant (rilpivirine hydrochloride) submitted by Janssen Products, LP. This action confirms regu…